Comments
Loading...
Actinium Pharma Earnings Estimates, EPS & Revenue | AMEX:ATNM | Benzinga
Actinium Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 28
EPS Estimate
$-0.390
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$81.00K
Analyze the earnings history of Actinium Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Actinium Pharma (ATNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.37 | $-0.36 | -2.78 % |
| Q2 | 2024-08-05 | $-0.38 | $-0.40 | 5.00 % |
| Q1 | 2024-04-26 | $-0.31 | $-0.52 | 40.4 % |
| Q4 | 2024-03-29 | $-0.33 | $-0.54 | 38.9 % |
Actinium Pharma (ATNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-02 | $0 | $570.00K | -100.0 % |
| Q4 | 2023-04-03 | $0 | $1.03M | -100.0 % |
FAQ
When is Actinium Pharma (AMEX:ATNM) reporting earnings?
Actinium Pharma (ATNM) is scheduled to report earnings on April 25, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Actinium Pharma (AMEX:ATNM)?
The Actual EPS was $-0.37, which missed the estimate of $-0.36.
What were Actinium Pharma’s (AMEX:ATNM) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.